It was reported to boston scientific corporation on january 22, 2018 that a wallflex duodenal soft uncovered stent was implanted from the descending part of the duodenum to the antrum of the stomach with the flared end fully inside the stomach to treat a 1 to 2 cm stenosis during a duodenal stent placement procedure performed on (b)(6) 2018.Reportedly, the stenosis was due to metastasis of the patient¿s lung cancer and was resulting in vomiting, the physician deployed the stent to reduce the vomiting.The patient¿s anatomy was moderately tortuous, was not dilated prior to stent placement and the intended stent placement site was in a significant bend.On (b)(6) 2018, the physician successfully implanted the wallflex duodenal soft uncovered stent.After placement on (b)(6) 2018 the stent dilation was reportedly not good.On (b)(6) 2018, no expansion was noted with the stent and patient still presented with vomiting so a stomach tube was inserted.On (b)(6) 2018, the patient presented with a fever and medication was administered.On (b)(6) 2018, a computed tomography (ct) scan was performed to check the stent and noted that the stent was not fully expanded.A blood test was taken and noted an inflammatory response.On (b)(6) 2018, the inflammatory response was noted to have worsened and a ct scan was performed which showed the stent had expanded but free air was noted.Perforation was found at the anterior wall of the stomach, near the ostium pyloricum, at the non-flared section of the stent.In the physician¿s assessment, the stent¿s expansion may have contributed to the perforation.Surgery to treat the perforation was considered, however, a conservative medical approach was followed due to the patient¿s condition (patient was non-ambulatory performance status 4).Meropenem hydrate(antibiotic) and thrombomodulin alfa were administered to the patient.On (b)(6) 2018, the patient expired due to sepsis and in the physician¿s assessment the sepsis was a result of the perforation.
|